ClinicalTrials.Veeva

Menu

Effects of Low-intensity Shockwave Therapy Versus Kegel Exercises on Arteriogenic Erectile Dysfunction in DM Patients

Cairo University (CU) logo

Cairo University (CU)

Status

Completed

Conditions

Shock Wave
Sexual Dysfunction

Treatments

Device: Low-intensity Shockwave Therapy
Other: Kegel Exercises

Study type

Interventional

Funder types

Other

Identifiers

NCT06058832
Shockwave in ED

Details and patient eligibility

About

  • To assess the effectiveness of low-intensity shockwave therapy (Li-ESWT) in the management of Arteriogenic erectile dysfunction in diabetic patients.
  • To assess the effectiveness of Kegel Exercises in the management of Arteriogenic erectile dysfunction in diabetic patients.
  • To compare the effectiveness of Li-ESWT and Kegel Exercises in the management of Arteriogenic erectile dysfunction in diabetic patients.

Full description

Erectile dysfunction is defined as the persistent inability to attain and maintain an erection enough to permit satisfactory sexual performance. Although ED is a benign disorder, it may affect physical and psychosocial health and may have a significant impact on the quality of life of sufferers and their partners.

According to the underlying causes, ED can be classified as psychogenic, endocrinologic, neurogenic, and vasculogenic. Vasculogenic erectile dysfunction is defined as an inability to get or keep an erection firm enough for sexual intercourse due to diseases such as diabetes mellitus and atherosclerotic vascular occlusive disease .

ED has been reported to occur in ≥50% of men with DM worldwide. It is usually present within 10 years of diagnosis of DM. The incidence of ED was reported to be higher in men with DM than for men without DM and up to 12% of men who present with ED were found to have previously undiagnosed DM.

Low-intensity extracorporeal shock wave therapy (Li-ESWT) was used in both in vitro and in vivo studies and the results showed that this energy can stimulate angiogenesis. The idea of applying Li-ESWT to the penis came from animal studies in which Li-ESWT was applied to the myocardium of pigs, where it has been reported that there was an improvement in ischemia-induced myocardial dysfunction.

Low-intensity extracorporeal SW therapy (Li-ESWT) of the penis would improve penile blood flow and endothelial function by stimulating angiogenesis in the corpora.

Oral phosphodiesterase-5 inhibitors (PDE-5 inhibitors), such as sildenafil and tadalafil, are usually the first-line treatment of erectile dysfunction. They are effective in a wide range of etiologies including cardiovascular disease, diabetes, and hypogonadism.

Contraction of the ischiocavernosus participates in the process of enhancing erectile rigidity by compressing the roots of the corpora cavernosa and inducing short-term suprasystolic intracavernosal pressures.

Further, bulbospongiosus contraction leads to temporary engorgement of the glans penis and corpus spongiosum and results in similar short-term increases in intra spongiosal pressures.

Enrollment

90 patients

Sex

Male

Ages

35 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Ninety married men were diagnosed with T2DM participated in this study.
  2. The patients complained from arteriogenic ED > 6 months (Reisman et al., 2015) before the participation in this study
  3. All patients aged between 35-55 years old.
  4. Glycated hemoglobin (HbA1c) less than 9%.
  5. Body mass index of the patients was < 30 Kg/m2.

Exclusion criteria

  1. Alcohol-abuse, illegal drug consumer patients.
  2. Patients with cardiac diseases that prevent or affect sexual activity (heart attack, stroke, heart failure, myocardial infarction life-threatening, arrhythmia, etc within the previous 6 months).
  3. Patients with any pulmonary, liver, or kidney diseases.
  4. Patients with neurological insults, spinal cord injuries, stroke, polyneuropathy, etc.
  5. Patients with diagnosed psychiatric/mental complaints.
  6. Patients with blood pressure of more than 140/90 mmHg.
  7. Patients with peripheral vascular disease.
  8. Patients with venogenic ED.
  9. Patients with past radical prostatectomy, extensive pelvic surgery, or previous pelvic trauma.
  10. Patients recovering from cancer in the past 5 years
  11. Penile anatomical abnormalities.
  12. Patients with clinically significant chronic hematological disease.
  13. Patients who received Anti-androgens or radiotherapy treatment of pelvic region.
  14. Patients with untreated hypogonadism.
  15. Patients with psychogenic ED (normal nocturnal penile tumescence parameters)
  16. Patient with penile prosthesis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

90 participants in 3 patient groups

Low-intensity Shockwave Therapy
Experimental group
Description:
patients will receive 6 sessions, once per week of low-intensity extracorporeal shock wave with the following parameters: - 3000 SWs (energy intensity of 0.09 mJ/mm2) to each of five different sites: three along the penile shaft and two at the crural level plus Sildenafil 25mg of daily dose and 50mg on-demand dose one hour before intercourse for 6 weeks.
Treatment:
Device: Low-intensity Shockwave Therapy
Kegel Exercises
Experimental group
Description:
kegel exercises plus sildenafil 25mg of daily dose and 50mg on-demand dose one hour before intercourse for 6 weeks.
Treatment:
Other: Kegel Exercises
control group
No Intervention group

Trial contacts and locations

1

Loading...

Central trial contact

Elsayed Abosteit, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems